Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7025962 Mammalian cell surface antigens; related reagents

Patent 7025962 was granted and assigned to Schering AG on April, 2006 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Schering AG
Schering AG
0
Date Filed
April 10, 2000
0
Date of Patent
April 11, 2006
0
Patent Application Number
09545998
0
Patent Citations Received
‌
US Patent 12083121 Substituted piperazines as KRAS G12C inhibitors
0
‌
US Patent 11944647 Articles of manufacture and methods for treatment using adoptive cell therapy
0
‌
US Patent 11945873 Antitumor antagonists
0
‌
US Patent 11993597 Inhibitors of KRAS G12C and methods of using the same
0
‌
US Patent 12006356 Anti-CCT5 binding molecules and chimeric antigen receptors comprising the same
0
‌
US Patent 12018073 Antagonists targeting the TGF-β pathway
0
‌
US Patent 11851493 Trispecific antagonists
0
‌
US Patent 11866507 Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same
0
‌
US Patent 11905281 KRAS G12C inhibitors and methods of using the same
0
‌
US Patent 11918584 Combination therapy including a KRAS
0
Patent Inventor Names
Albert Zlotnik
0
Daniel M. Gorman
0
Troy D. Randall
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7025962
0
Patent Primary Examiner
‌
Ronald B. Schwadron
0

Find more entities like US Patent 7025962 Mammalian cell surface antigens; related reagents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.